Publications

Filters
September 24, 2019

Debio 1143 Mode of Action: a Broad Chemo-Radio and Immuno-Therapy Sensitizer

Read more
September 24, 2019

Squamous Cell Carcinoma Of The Head & Neck (SCCHN) – Infographic

Read more
September 19, 2019

Cholecystokinin-2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma – Results of the Lumed Phase 0a Study

Read more
July 4, 2019

DEBIO 1347 In Patients With GastroIntestinal Cancers Harboring An FGFR Gene Fusion: Preliminary Results

Read more
June 1, 2019

A dose-finding study of the SMAC mimetic Debio 1143 when given in combination with avelumab to patients with advanced solid…

Read more
June 1, 2019

FUZE Clinical Trial: a Phase 2 study of Debio 1347 in FGFR fusion-positive advanced solid tumors irrespectively of the tumor histology

Read more
April 16, 2019

New sample preparation method enabling PCR-based pathogen identification directly from blood to accelerate blood stream infection (BSI) diagnosis

Read more
April 3, 2019

Open-label, non-randomized, exploratory pre-operative window-of-opportunity trial to investigate the pharmacokinetics and pharmacodynamics of the smac mimetic Debio 1143 in patients…

Read more
April 3, 2019

Molecular screening of patients with FGFR alterations for a phase 1 (Ph1) study with the selective FGFR inhibitor (FGFRi) Debio…

Read more